Johnson & Johnson
JNJ
#22
Rank
NZ$1.167 T
Marketcap
NZ$485.04
Share price
-0.73%
Change (1 day)
47.04%
Change (1 year)

Johnson & Johnson is a global American pharmaceutical and consumer goods company with headquarters in New Brunswick, New Jersey. The company is listed in the Dow Jones Industrial Average.

EPS for Johnson & Johnson (JNJ)

EPS in 2026 (TTM): NZ$15.18

According to Johnson & Johnson's latest financial reports the company's current EPS (TTM) is NZ$15.51. In 2025 the company made an earnings per share (EPS) of NZ$19.78 an increase over its 2024 EPS that were of NZ$11.88.

EPS history for Johnson & Johnson from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ$15.18-23.23%
2025NZ$19.7866.46%
2024NZ$11.88-53.6%
2023NZ$25.60111.16%
2022NZ$12.13-13.84%
2021NZ$14.0741.81%
2020NZ$9.92-18.92%
2019NZ$12.2421.2%
2018NZ$10.101125.3%
2017NZ$0.82-92.23%
2016NZ$10.607.37%
2015NZ$9.88-4.16%
2014NZ$10.3018.1%
2013NZ$8.7224.88%
2012NZ$6.99

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
NZ$11.82-23.74%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$1.35-91.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$5.54-64.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
NZ$7.24-53.28%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Eli Lilly
LLY
NZ$53.06 242.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$3.38-78.21%๐Ÿ‡ซ๐Ÿ‡ท France
Gilead Sciences
GILD
NZ-$4.62-129.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Stryker Corporation
SYK
NZ$17.27 11.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$2.25-85.51%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$5.68-63.39%๐Ÿ‡ฌ๐Ÿ‡ง UK